We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
Date | Subject | Author | Discuss |
---|---|---|---|
03/7/2019 16:56 | 1710p on the cards. | montyhedge | |
03/7/2019 16:54 | Out at 1643p and hoping Porche is right about his trading range from 1520p? | warranty | |
03/7/2019 16:44 | Zorija Thanks, how do I give them the bank instruction? Do I contact my broker? | bazzerhino | |
03/7/2019 16:13 | Thanks CrossingRubicon... understand where you're coming from in that case. | sogoesit | |
03/7/2019 15:47 | pie, your preference either bank instruction or chg through post.. Edit - I have some held in nominee and these paid via broker into my bank account and some held via certificate. The latter are split between cheques and sums paid directly into accounts... ZZZ | zorija | |
03/7/2019 15:02 | @Sogo. US/China trade optimism going to end in disappointment. A global recession is coming. Debt bubbles a bursting. | crossing_the_rubicon | |
03/7/2019 14:35 | Do Glaxosmithkline pay dividends by post or directly to your bank out? | piefacefrank | |
03/7/2019 13:08 | Why the FTSE-100? Trade optimism, or resolution, will favour US equities. Cable probably structurally "weak" on terms of trade while an independent UK adjusts. Resumption of China trade should favour commodities. | sogoesit | |
03/7/2019 12:29 | Presumably continued Sterling weakness responsible for a good chunk of this recent rise. But good news on top never goes amiss. Must be a SELL soon, ditto the FTSE100. | crossing_the_rubicon | |
03/7/2019 12:04 | I'm waiting for 1650.5 for my sell order to be executed.:-) | sicker | |
03/7/2019 11:38 | Must be a lot more good news on the way to explain this recent climb? | tradermichael | |
03/7/2019 09:26 | More good news I see.... ViiV receives Dovato EU Marketing application" "A new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection" htTTps://www.busines | crossing_the_rubicon | |
03/7/2019 09:26 | Well on the way to breaking through 52 week high of 1648p, maybe even today. Resistance could then become support. | bluemango | |
03/7/2019 09:24 | U.S. stocks markets are closed on Thursday in observance of Independence Day and will close early at 1 p.m. ET on Wednesday. | tradermichael | |
03/7/2019 09:17 | I bet loads of shorts have their stops near here could drive it higher as it takes them out. | tim 3 | |
03/7/2019 09:10 | Porsche19452 Jul '19 - 11:12 - 19747 of 19762 0 2 0 Nose bleed time...then weee back to sub 15.20 for next nice juicy trading profit, dont you just love range bound shares. Even the brexit knuckle draggers on here will be able to grasp that.... too right Porsche - spot on analysis | harry the haddock | |
03/7/2019 08:41 | Q1 pay date is 11 July …. can't wait to buy some more …. ;0) | tradermichael | |
03/7/2019 08:31 | Indeed, aurelius, compression and a bit of volatility reduction has given the break-out. | sogoesit | |
03/7/2019 08:28 | Strong graph. amazing recovery from 1250p 18 months ago. looking good . The weakness of sterling not yet fully factored into share price for GSK who derive so much income from overseas. ALL IMO. DYOR. QP | quepassa | |
02/7/2019 22:54 | Chart wise the odds still favour a pullback below 1600 but every time it breaks above they decrease. Happy to hold here for long term. | tim 3 | |
02/7/2019 20:38 | The share price has been increasingly compressed over the last year. A breakout could be coming over the next few months. | aurelius5 | |
02/7/2019 20:10 | GlaxoSmithKline (GSK +0.1%) raised the price of ovarian cancer med Zejula (niraparib), acquired in Tesaro merger, by 5% to $6,913 for a 30-day supply. | crossing_the_rubicon | |
02/7/2019 17:43 | trading at 21 times earnings....to high....may go a little higher with ftse, back to 15 by aug | porsche1945 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions